22157.jpg
$4.31 Billion Worldwide Hematology Analyzers and Reagents Industry to 2030 - Identify Growth Segments for Investment
30 déc. 2021 05h33 HE | Research and Markets
Dublin, Dec. 30, 2021 (GLOBE NEWSWIRE) -- The "Hematology Analyzers and Reagents Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's...
ADPT new logo.jpg
Adaptive Biotechnologies Announces New Data Demonstrating the Benefit of Serial MRD Testing with the clonoSEQ® Assay in Patients with Blood Cancers at the 63rd ASH Annual Meeting
13 déc. 2021 16h05 HE | Adaptive Biotechnologies
Analysis of the MASTER trial (Abstract 481) showed clonoSEQ’s ability to measure deep and durable responses and permit treatment discontinuation in multiple myeloma patientsData in more than 30...
ExCellThera_RGB.png
ExCellThera announces data to be presented at the American Society of Hematology 2021 annual meeting
29 nov. 2021 08h05 HE | ExCellThera
MONTRÉAL, Nov. 29, 2021 (GLOBE NEWSWIRE) -- ExCellThera Inc., a clinical-stage cell expansion and engineering company delivering molecules and bioengineering solutions to expand and engineer...
3-Year Global MPN Interferon Initiative Report Released by MPN Research Foundation
01 nov. 2021 08h45 HE | MPN Research Foundation
Chicago, IL, Nov. 01, 2021 (GLOBE NEWSWIRE) -- In real-world usage and in clinical trials, interferon (IFN) in a variety of forms has shown high rates of hematologic and molecular responses in many...
The MDS Foundation Celebrates MDS World Awareness Day With Their 4th Annual Move for MDS 5k Walk at Boston Common and Virtually Around the World
20 oct. 2021 10h05 HE | MDS Foundation, Inc.
YARDVILLE, N.J., Oct. 20, 2021 (GLOBE NEWSWIRE) -- The MDS Foundation, a global non-profit advocacy organization is proud to announce its fourth annual Move for MDS walk at Boston Common on Sunday,...
22157.jpg
Global Oncology Based In-vivo CRO Markets to 2028 by Indication (Blood Cancer, Solid Tumor), Model (Syngeneic Model, Patient Derived Xenograft (PDX), Xenograft),
15 oct. 2021 05h08 HE | Research and Markets
Dublin, Oct. 15, 2021 (GLOBE NEWSWIRE) -- The "Global Oncology Based In-vivo CRO Market Size, Share & Trends Analysis Report by Indication (Blood Cancer, Solid Tumor), by Model (Syngeneic Model,...
22157.jpg
Worldwide Hematology Analyzers and Reagents Industry to 2027 - Increasing Incidence of Hematologic Diseases is Driving Growth
31 août 2021 04h18 HE | Research and Markets
Dublin, Aug. 31, 2021 (GLOBE NEWSWIRE) -- The "Hematology Analyzers and Reagents Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product and Service; Application; End User, and...
22157.jpg
Global Oncology Based In-Vivo CRO Markets, 2021-2027: Focus on Solid Tumors, Blood Cancer, Other Indications
27 juil. 2021 08h08 HE | Research and Markets
Dublin, July 27, 2021 (GLOBE NEWSWIRE) -- The "Oncology Based In-Vivo CRO - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Global Oncology...
TIP_link_300x300.jpg
Hematology Analyzers and Reagents Market Growth Sturdy at 7.6% CAGR to Outstrip $13,007.87 Million by 2027 - COVID-19 Impact and Global Analysis by TheInsightPartners.com
07 juin 2021 10h46 HE | The Insight Partners
Pune, India., June 07, 2021 (GLOBE NEWSWIRE) -- Hematology Analyzers and Reagents Market: Key InsightsAccording to our new research study on “Hematology Analyzers and Reagents Market to 2027 –...
ExCellThera_RGB.png
Excellthera and Ossium Health Announce a Collaboration to Advance Their Technologies and Platforms to Improve Human Health
21 avr. 2021 08h02 HE | ExCellThera
MONTREAL, April 21, 2021 (GLOBE NEWSWIRE) -- ExCellThera Inc., a clinical-stage cell and molecular medicine company delivering molecules and bioengineering solutions to expand stem and immune cells...